Zejula (niraparib tosylate): Reviews and patient testimonials


/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1720004028

Back Back to the list of medications

Medication indications

Zejula 100 mg hard capsules

Zejula is indicated as monotherapy for the maintenance treatment of adult patients with platinum-sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum-based chemotherapy.


Route of administration: Oral
Molecule: niraparib tosylate

Patients' opinions on Zejula

In brief

General satisfaction level: 8.00/10 Learn more

Treatment's effectiveness: Be the first to evaluate

Ease of use: 8.00/10 Learn more

Adherence to prescription: 10.00/10 Learn more

Detected side effects: 3.00/10 Learn more

Improvement in the quality of life: 8.00/10 Learn more

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

Join Carenity and be the first to give your opinion on this medication.